Literature DB >> 8391359

An optimal time control problem for the administration of 2',3'-dideoxycytidine by using red blood cells as bioreactors.

E Beretta1, F Solimano.   

Abstract

The problem of optimal dosage is studied for the administration of ddCyd using erythrocytes as carriers and bioreactors. The volume of erythrocytes and the initial amount of drug to be loaded have to be determined in such a way that the duration of the therapeutic effect is maximized without exceeding the toxic threshold. It is found that the optimal control is unique and it is at the upper vertex of the set of the admissible controls. A more general case is also briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391359     DOI: 10.1007/bf02460670

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  4 in total

1.  2',3'-dideoxycytidine permeation of the human erythrocyte membrane.

Authors:  M Magnani; M Bianchi; L Rossi; V Stocchi
Journal:  Biochem Int       Date:  1989-08

2.  Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity.

Authors:  M Magnani; M Bianchi; L Rossi; V Stocchi
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

3.  Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

Authors:  H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

4.  A nonlinear three-compartment model for the administration of 2',3'-dideoxycytidine by using red blood cells as bioreactors.

Authors:  F Solimano; G I Bischi; M Bianchi; L Rossi; M Magnani
Journal:  Bull Math Biol       Date:  1990       Impact factor: 1.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.